{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:36:47Z","timestamp":1788316607990,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1998,2,1]],"date-time":"1998-02-01T00:00:00Z","timestamp":886291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1998,2,1]],"date-time":"1998-02-01T00:00:00Z","timestamp":886291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[1998,2]]},"DOI":"10.1124\/mol.53.2.304","type":"journal-article","created":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T20:29:28Z","timestamp":1515443368000},"page":"304-312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["M2 Receptor Binding of the Selective Antagonist AF-DX 384: Possible Involvement of the Common Allosteric Site"],"prefix":"10.1016","volume":"53","author":[{"given":"C.","family":"Tr\u00e4nkle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Andresen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Lambrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Mohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.53.2.304_bib1","first-page":"48","article-title":"Some quantitative uses of drug antagonists.","volume":"14","author":"Arunlakshana","year":"1959","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.53.2.304_bib2","doi-asserted-by":"crossref","unstructured":"Birdsall NJM, Chan SC, Eveleigh P, Hulme EC, and Miller KW (1989) The modes of binding of ligands to cardiac muscarinic receptors.Trends Pharmacol Sci10(suppl.):31\u201334.","DOI":"10.1007\/978-1-4612-4498-1_2"},{"key":"10.1124\/mol.53.2.304_bib3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0026-895X(25)08651-1","article-title":"Assessment of the allosteric interactions of the bisquaternary heptane-1,7-bis(dimethyl-3\u2032-phthalimido-propyl)ammonium bromide at M1 and M2 muscarine receptors.","volume":"46","author":"Christopoulos","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.53.2.304_bib4","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1476-5381.1976.tb07708.x","article-title":"The inhibitory effect of gallamine on muscarinic receptors.","volume":"58","author":"Clark","year":"1976","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.53.2.304_bib5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0165-6147(89)90266-6","article-title":"Calculating receptor number from binding experiments using same compound as radioligand and competitor.","volume":"10","author":"DeBlasi","year":"1989","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/mol.53.2.304_bib6","unstructured":"Eberlein WG, Engel W, Mihm G, Rudolf K, Wetzel B, Entzeroth M, Mayer N, and Doods HN (1989) Structure-activity relationships and pharmacological profile of selective tricyclic antimuscarinics.Trends Pharmacol Sci10(suppl.):50\u201354."},{"key":"10.1124\/mol.53.2.304_bib7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0026-895X(25)13145-3","article-title":"Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods.","volume":"35","author":"Ehlert","year":"1988","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.53.2.304_bib8","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0026-895X(25)09006-6","article-title":"Two allosteric modulators interact at a common site on cardiac muscarinic receptors.","volume":"42","author":"Ellis","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.53.2.304_bib9","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/0006-2952(91)90591-R","article-title":"Allosteric regulation of cloned m1\u2013m5 muscarinic receptor subtypes.","volume":"42","author":"Ellis","year":"1991","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.53.2.304_bib10","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0026-895X(25)13228-8","article-title":"Use of chimeric muscarinic receptors to investigate epitopes involved in allosteric interactions.","volume":"44","author":"Ellis","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.53.2.304_bib11","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/0006-2952(90)90473-X","article-title":"Labeling of rat heart muscarinic receptors using the new M2 selective antagonist [3H]AF-DX 384.","volume":"40","author":"Entzeroth","year":"1990","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.53.2.304_bib12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0922-4106(92)90026-R","article-title":"Agonist-independent inhibition of G protein activation by muscarinic acetylcholine receptor antagonists in cardiac membranes.","volume":"225","author":"Hilf","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/mol.53.2.304_bib13","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0922-4106(95)90109-4","article-title":"Positive interactions on cardiac muscarinic receptors: effect of chemical modifications of disulphide and carboxyl groups.","volume":"289","author":"Jakub\u0131\u0301k","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/mol.53.2.304_bib14","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0022-3565(25)10553-3","article-title":"Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic receptor subtypes.","volume":"274","author":"Jakub\u0131\u0301k","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.53.2.304_bib15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1600-0773.1988.tb00932.x","article-title":"Allosteric stabilisation of [3H]-N-methylscopolamine binding in guinea pig myocardium by an antidote against organophosphate intoxication.","volume":"63","author":"Jepsen","year":"1988","journal-title":"Pharmacol Toxicol"},{"key":"10.1124\/mol.53.2.304_bib16","first-page":"566","article-title":"Conformational analysis and receptor modelling of m1 and m2 selective antagonists.","volume":"49","author":"Kerckhoff","year":"1994","journal-title":"Pharmazie"},{"key":"10.1124\/mol.53.2.304_bib17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0165-6147(97)88188-6","article-title":"Composite action of allosteric modulators on ligand binding (letter reply).","volume":"17","author":"Kostenis","year":"1996","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/mol.53.2.304_bib18","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/0223-5234(94)90194-5","article-title":"Allosteric effect on muscarinic M2-receptors of derivatives of the alkane-bis-ammonium compound W84: comparison with bispyridinium-type allosteric modulators.","volume":"29","author":"Kostenis","year":"1994","journal-title":"Eur J Med Chem"},{"key":"10.1124\/mol.53.2.304_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0014-2999(96)00639-5","article-title":"Interactions of agonists with an allosteric antagonist at muscarinic acetylcholine M2 receptors.","volume":"316","author":"Lanzafame","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/mol.53.2.304_bib20","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/j.1476-5381.1993.tb13737.x","article-title":"Estimation of competitive antagonist affinity from functional inhibition curves using the Gaddum, Schild and Cheng-Prusoff equations.","volume":"109","author":"Lazareno","year":"1993","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.53.2.304_bib21","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0026-895X(25)10255-1","article-title":"Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interaction of strychnine and acetylcholine at muscarinic receptors.","volume":"48","author":"Lazareno","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.53.2.304_bib22","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0022-3565(25)22221-2","article-title":"Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors: identification of three main types of gallamine-muscarinic receptor interaction.","volume":"246","author":"Lee","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.53.2.304_bib23","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0022-3565(25)23154-8","article-title":"Allosteric interactions at the m1, m2 and m3 muscarinic receptor subtypes.","volume":"256","author":"Lee","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.53.2.304_bib24","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0026-895X(25)10214-9","article-title":"Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic acetylcholine receptor.","volume":"45","author":"Leppik","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.53.2.304_bib25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0014-2999(69)90181-2","article-title":"Inhibition of the actions of carbachol and DFP on guinea pig isolated atria by alkane-bis-ammonium compounds.","volume":"6","author":"L\u00fcllmann","year":"1969","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/mol.53.2.304_bib26","first-page":"R101","article-title":"Comparison between the stabilizing effects of W84 on [3H]NMS-binding in cardiac membranes and in beating atria from guinea pig hearts.","volume":"345","author":"L\u00fc\u03b2","year":"1992","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"10.1124\/mol.53.2.304_bib27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0014-2999(94)00664-S","article-title":"Potentiation by alcuronium of the antimuscarinic effect of N-methylscopolamine in guinea pig left atria.","volume":"272","author":"Maa\u03b2","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/mol.53.2.304_bib28","unstructured":"Melchiorre C, Minarini A, Angeli P, Giardina D, Gulini U, and Quaglia W (1989) Polymethylene tetramines as muscarinic receptor probes.Trends Pharmacol Sci 4(suppl.):50\u201354."},{"key":"10.1124\/mol.53.2.304_bib29","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0022-3565(25)20469-4","article-title":"Binding of [3H]AF-DX 384 to cloned and native muscarinic receptors.","volume":"259","author":"Miller","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.53.2.304_bib30","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/j.1476-5381.1991.tb09827.x","article-title":"Modulation of the structure-binding relationships of antagonists for muscarinic acetylcholine receptor subtypes.","volume":"103","author":"Pedder","year":"1991","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.53.2.304_bib31","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0026-895X(25)10157-0","article-title":"Mechanisms of steric and cooperative actions of alcuronium on cardiac muscarinic acetylcholine receptors.","volume":"45","author":"Pros\u0306ka","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.53.2.304_bib32","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1124\/mol.51.4.674","article-title":"Divergent modes of action among cationic allosteric modulators of muscarinic M2 receptors.","volume":"51","author":"Tr\u00e4nkle","year":"1997","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.53.2.304_bib33","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0022-3565(25)21206-X","article-title":"Search for lead structures to develop new allosteric modulators of muscarinic receptors.","volume":"279","author":"Tr\u00e4nkle","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.53.2.304_bib34","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1021\/jm00097a002","article-title":"Modeling of G-protein-coupled receptors: application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors.","volume":"35","author":"Trumpp-Kallmeyer","year":"1992","journal-title":"J Med Chem"},{"key":"10.1124\/mol.53.2.304_bib35","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1476-5381.1994.tb13102.x","article-title":"Binding and functional properties of hexocyclium and sila-hexocyclium derivatives to muscarinic receptor subtypes.","volume":"112","author":"Waelbroeck","year":"1994","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.53.2.304_bib36","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1476-5381.1996.tb16041.x","article-title":"Stereoselective recognition of the enantiomers of phenylglutarimide and of six related compounds by four muscarinic receptor subtypes.","volume":"119","author":"Waelbroeck","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.53.2.304_bib37","series-title":"Untersuchungen zur Pharmakokinetik bis-quart\u00e4rer Substanzen in vivo und in vitro.","author":"Wassermann","year":"1970"},{"key":"10.1124\/mol.53.2.304_bib38","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0165-6147(93)90049-P","article-title":"Molecular basis of muscarinic acetylcholine receptor function.","volume":"14","author":"Wess","year":"1993","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/mol.53.2.304_bib39","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0026-895X(25)08886-8","article-title":"Structural basis of the subtype selectivity of muscarinic antagonists: a study with chimeric m2\/m5 muscarinic receptors.","volume":"41","author":"Wess","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.53.2.304_bib40","first-page":"19","article-title":"Peptide mapping studies on muscarinic receptors: receptor structure and location of the ligand binding site.","volume":"9","author":"Wheatley","year":"1988","journal-title":"Trends Pharmacol Sci"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24131835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24131835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.53.2.304","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T10:01:18Z","timestamp":1740045678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24131835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,2]]}},"alternative-id":["S0026895X24131835"],"URL":"https:\/\/doi.org\/10.1124\/mol.53.2.304","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[1998,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"M2 Receptor Binding of the Selective Antagonist AF-DX 384: Possible Involvement of the Common Allosteric Site","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.53.2.304","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 1998 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}